Advanced search
1 file | 1.22 MB Add to list

Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

(2018) CANCER RESEARCH. 78(2). p.463-474
Author
Organization
Keywords
CHECKPOINT BLOCKADE, CANCER-THERAPY, PD-1 BLOCKADE, IMMUNOGENIC TUMORS, CLINICAL USE, T-CELLS, IMMUNOTHERAPY, TOXICITIES, MELANOMA, EFFICACY

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.22 MB

Citation

Please use this url to cite or link to this publication:

MLA
Cauwels, Anje, et al. “Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.” CANCER RESEARCH, vol. 78, no. 2, 2018, pp. 463–74, doi:10.1158/0008-5472.CAN-17-1980.
APA
Cauwels, A., Van Lint, S., Paul, F., Garcin, G., De Koker, S., Van Parys, A., … Tavernier, J. (2018). Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments. CANCER RESEARCH, 78(2), 463–474. https://doi.org/10.1158/0008-5472.CAN-17-1980
Chicago author-date
Cauwels, Anje, Sandra Van Lint, Franciane Paul, Genevieve Garcin, Stefaan De Koker, Alexander Van Parys, Thomas Wüest, et al. 2018. “Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.” CANCER RESEARCH 78 (2): 463–74. https://doi.org/10.1158/0008-5472.CAN-17-1980.
Chicago author-date (all authors)
Cauwels, Anje, Sandra Van Lint, Franciane Paul, Genevieve Garcin, Stefaan De Koker, Alexander Van Parys, Thomas Wüest, Sarah Gerlo, José Van Der Heyden, Yan Bordat, Dominiek Catteeuw, Elke Rogge, Annick Verhee, Bart Vandekerckhove, Nico Kley, Gilles Uzé, and Jan Tavernier. 2018. “Delivering Type I Interferon to Dendritic Cells Empowers Tumor Eradication and Immune Combination Treatments.” CANCER RESEARCH 78 (2): 463–474. doi:10.1158/0008-5472.CAN-17-1980.
Vancouver
1.
Cauwels A, Van Lint S, Paul F, Garcin G, De Koker S, Van Parys A, et al. Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments. CANCER RESEARCH. 2018;78(2):463–74.
IEEE
[1]
A. Cauwels et al., “Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments,” CANCER RESEARCH, vol. 78, no. 2, pp. 463–474, 2018.
@article{8550247,
  author       = {{Cauwels, Anje and Van Lint, Sandra and Paul, Franciane and Garcin, Genevieve and De Koker, Stefaan and Van Parys, Alexander and Wüest, Thomas and Gerlo, Sarah and Van Der Heyden, José and Bordat, Yan and Catteeuw, Dominiek and Rogge, Elke and Verhee, Annick and Vandekerckhove, Bart and Kley, Nico and Uzé, Gilles and Tavernier, Jan}},
  issn         = {{0008-5472}},
  journal      = {{CANCER RESEARCH}},
  keywords     = {{CHECKPOINT BLOCKADE,CANCER-THERAPY,PD-1 BLOCKADE,IMMUNOGENIC TUMORS,CLINICAL USE,T-CELLS,IMMUNOTHERAPY,TOXICITIES,MELANOMA,EFFICACY}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{463--474}},
  title        = {{Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments}},
  url          = {{http://doi.org/10.1158/0008-5472.CAN-17-1980}},
  volume       = {{78}},
  year         = {{2018}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: